Trial Profile
An Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids With Further CSA Elimination In The Rapamune Arm With The Introduction Of MMF
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Sirolimus (Primary) ; Ciclosporin; Corticosteroids; Mycophenolate mofetil
- Indications Transplant rejection
- Focus Adverse reactions; Biomarker; Therapeutic Use
- Sponsors Pfizer
- 23 May 2012 New trial record